Potential biomarkers for diagnosis of Alzheimer’s disease

Potential biomarkers for diagnosis of Alzheimer’s disease

Researchers identify abnormal expression of genes, resulting from DNA relaxation, that can be detected in the brain and blood of Alzheimer’s patients.

via Top Health News — ScienceDaily:

Date:January 31, 2014Source:Brigham and Women’s HospitalSummary:Researchers identify abnormal expression of genes, resulting from DNA relaxation, that can be detected in the brain and blood of Alzheimer’s patients.In a study published this week in Nature Neuroscience, Bess Frost, PhD, and co-authors, identify abnormal expression of genes, resulting from DNA relaxation, that can be detected in the brain and blood of Alzheimer’s patients.The protein tau is involved in a number of neurodegenerative disorders, including Alzheimer’s disease. Previous studies have implicated DNA damage as a cause of neuron, or cell, death in Alzheimer’s patients. Given that DNA damage can change the structure of DNA within cells, the researchers examined changes in DNA structure in tau-induced neurodegeneration. They used transgenic flies and mice expressing human tau to show that DNA is more relaxed in tauopathy. They then identified that the relaxation of tightly wound DNA and resulting abnormal gene expression are central events that cause neurons to die in Alzheimer’s disease.The authors write, “Our work suggests that drugs that modify DNA structure may be beneficial for treating Alzheimer’s Disease.” The authors recommend, “A greater understanding of the pathway of DNA relaxation in tauopathies will allow us to identify the optimal target and explore the therapeutic potential of epigenetic-based drugs.”Story Source:The above story is based on materials provided by Brigham and Women’s Hospital. Note: Materials may be edited for content and length.Journal Reference:Bess Frost, Martin Hemberg, Jada Lewis, Mel B Feany. Tau promotes neurodegeneration through global chromatin relaxation. Nature Neuroscience, 2014; DOI: 10.1038/nn.3639 Cite This Page:MLA APA Chicago Brigham and Women’s Hospital. “Potential biomarkers for diagnosis of Alzheimer’s disease.” ScienceDaily. ScienceDaily, 31 January 2014. …

For more info: Potential biomarkers for diagnosis of Alzheimer’s disease

Top Health News — ScienceDaily

Potential biomarkers for diagnosis of Alzheimer’s disease

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close